Literature DB >> 3106358

Diacylglycerol increases cytosolic free Ca2+ concentration in rat pituitary cells. Relationship to thyrotropin-releasing hormone action.

P R Albert, G Wolfson, A H Tashjian.   

Abstract

To elucidate possible functions of elevation of endogenous diacylglycerol induced by thyrotropin-releasing hormone in pituitary cells, we have studied the actions of two synthetic diacylglycerols, sn-1-oleoyl-2-acetylglycerol (OAG) and sn-1,2-dioctanoylglycerol (DiC8), on cytosolic free calcium concentration ([Ca2+]i) in GH4C1 cells. OAG induced an immediate increase in [Ca2+]i which gradually reached a peak that was twice the basal level after the first min; [Ca2+]i then returned to remain at basal level after 3 min. The increase in [Ca2+]i was dependent on the concentration of OAG added with two apparent potencies; half-maximal actions on [Ca2+]i were observed at 70 nM and greater than 20 microM. The increase in [Ca2+]i induced by OAG was blocked completely by chelating extracellular calcium, or by pretreatment with calcium channel blockers. The phorbol ester 12-O-tetradecanoylphorbol-13-acetate, which itself induces a rise in [Ca2+]i in these cells that is similar in time course, magnitude, and drug sensitivity to that of OAG, blocked completely the actions of subsequent exposure to OAG. Analogous results were obtained using DiC8, although DiC8 induced a transient inhibition to 75% of basal levels of [Ca2+]i after the initial increase in [Ca2+]i, and DiC8 was less potent than OAG. These data indicated that diacylglycerols induce influx of extracellular calcium in these cells, possibly by activation of voltage-dependent Ca2+ channels. Furthermore, diacylglycerols and phorbol esters appear to utilize a common pathway in eliciting these actions on [Ca2+]i, possibly involving activation of a protein kinase C. These actions of diacylglycerol provide a pathway by which thyrotropin-releasing hormone may act to enhance calcium channel activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106358

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Protein kinase C acts downstream of calcium at entry into the first mitotic interphase of Xenopus laevis.

Authors:  W M Bement; D G Capco
Journal:  Cell Regul       Date:  1990-02

2.  The diacylglycerol analogue, 1,2-sn-dioctanoylglycerol, induces an increase in cytosolic free Ca2+ and cytosolic acidification of T lymphocytes through a protein kinase C-independent process.

Authors:  R Ebanks; C Roifman; A Mellors; G B Mills
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

3.  cAMP- and diacylglycerol-mediated pathways elevate cytosolic free calcium concentration via dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels in normal rat anterior pituitary cells.

Authors:  C Schöfl; K Meier; D M Götz; W Knepel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Mechanism of spontaneous intracellular calcium fluctuations in single GH4C1 rat pituitary cells.

Authors:  K A Wagner; P W Yacono; D E Golan; A H Tashjian
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

5.  Limited accumulation of cyclic AMP underlies a modest vasoactive-intestinal-peptide-mediated increase in cytosolic [Ca2+] transients in GH3 pituitary cells.

Authors:  P Mollard; Y Zhang; D Rodman; D M Cooper
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

6.  Influence of phorbol esters, and diacylglycerol kinase and lipase inhibitors on noradrenaline release and phosphoinositide hydrolysis in chromaffin cells.

Authors:  J A Jones; P J Owen; M R Boarder
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

7.  Calcium transients during Fc receptor-mediated and nonspecific phagocytosis by murine peritoneal macrophages.

Authors:  T Hishikawa; J Y Cheung; R V Yelamarty; D W Knutson
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.